N/A
N=67
Epidemiology Non-cholera Vibrio Infections
Vibrio Infections
Bottom Line
View on ClinicalTrials.gov: NCT04451707 ↗Enrolled (actual)
67
Serious AEs
52.2%
Results posted
Mar 2021
Primary outcome: Primary: Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection — 20; 7; 2; 18 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- non-cholera Vibrio infection (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Groupe Hospitalier de la Rochelle Ré Aunis
- Primary completion
- Jun 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection |
20; 7; 2; 18; 10; 1 | — |
| SECONDARY Number of Patients Per Clinical History |
24; 11; 8; 7; 7; 5 | — |
| SECONDARY Number of Participants Associated With Environmental Factors |
12; 5; 3; 2; 7; 7 | — |
| SECONDARY Number of Participants Per Identified Species |
23; 20; 10; 7; 7 | — |
| SECONDARY Number of Participants by Month of the Years |
0; 0; 1; 0; 1; 6 | — |
| SECONDARY Number of Participants Treated by Antibiotics |
53; 5; 9 | — |
| SECONDARY Number of Participants Per Outcome |
53; 6; 8 | — |
Summary
The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.
Eligibility Criteria
Inclusion Criteria
- non-cholera Vibrio infection
Exclusion Criteria
- vibriosis to Vibrio cholerae O1 and O139
Data sourced from ClinicalTrials.gov (NCT04451707). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.